Gene: MMUT
Official Full Name: methylmalonyl-CoA mutaseprovided by HGNC
Gene Summary: This gene encodes the mitochondrial enzyme methylmalonyl Coenzyme A mutase. In humans, the product of this gene is a vitamin B12-dependent enzyme which catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA, while in other species this enzyme may have different functions. Mutations in this gene may lead to various types of methylmalonic aciduria. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36521 | MMUT Knockout cell line (HeLa) | Human | MMUT | 1:3~1:6 | Negative | Online Inquiry |
KO36522 | MMUT Knockout cell line (HCT 116) | Human | MMUT | 1:2~1:4 | Negative | Online Inquiry |
KO36523 | MMUT Knockout cell line (HEK293) | Human | MMUT | 1:3~1:6 | Negative | Online Inquiry |
KO36524 | MMUT Knockout cell line (A549) | Human | MMUT | 1:3~1:4 | Negative | Online Inquiry |
MMUT Gene Knockout Cell Lines are specialized cell lines engineered to lack functional expression of the malonate semialdehyde decarboxylase (MMUT) gene, which encodes an enzyme critical for proper mitochondrial function and metabolic processes. These cell lines serve as valuable tools for investigating the biological role of MMUT and understanding the pathophysiology of related metabolic disorders, particularly in the context of methylmalonic acidemia and other organic acidemias.
The key function of MMUT Gene Knockout Cell Lines lies in their ability to mimic the metabolic dysfunction observed in patients with MMUT deficiency. By eliminating MMUT activity, these cell lines allow researchers to assess the resultant biochemical alterations, including accumulated toxic metabolites such as methylmalonic acid. The mechanisms by which these alterations impact cellular metabolism can be studied extensively, providing insights into metabolic pathways and potential therapeutic targets.
The scientific importance of these cell lines is underscored by their applicability in both research and clinical settings. They are invaluable for drug discovery, enabling researchers to screen potential therapeutic agents aimed at alleviating the effects of MMUT insufficiency. Furthermore, they serve a crucial role in gene therapy studies and the development of newborn screening techniques to identify at-risk infants for early intervention.
Compared to alternative methods, such as using primary cells or other genetically modified models, MMUT Gene Knockout Cell Lines offer several distinct advantages. They provide a consistent, reproducible source of cells for experiments and allow for high-throughput screening, making them a cost-effective solution for research applications. Their ease of cultivation and genetic stability ensure that researchers can make reliable comparisons and draw significant conclusions.
The value of MMUT Gene Knockout Cell Lines to researchers, clinicians, and biotech companies cannot be overstated; they not only facilitate a deeper understanding of mitochondrial dysfunction and metabolic diseases but also pave the way for innovative therapeutic strategies that can enhance patient outcomes. Our company specializes in the development of high-quality biological products, ensuring that each cell line is meticulously validated to meet the rigorous standards of the scientific community, providing you with the tools necessary for groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.